Filed: 8/12/2025ACC: 0001104659-25-076821
📋 What this filing means
FORESITE CAPITAL MANAGEMENT VI LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $177.88M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$177.88M
Total AUM (reported)
19.24M
Total Shares
Allocation by class
COM$149.14M83.8%
SPONSORED ADS$20.82M11.7%
CL A$6.99M3.9%
ORD SHS$928.8K0.5%
Portfolio Concentration
Top 3$87.30M49.1%
4–10$62.03M34.9%
11–25$28.56M16.1%
Top 3 weight
49.1%
Top 10 weight
83.9%
Voting Authority Distribution
Total shares with voting rights: 19.24M
Sole
Full voting authority
19.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
CG Oncology, Inc.
SOLEShares2.22M
TypeSH
Market value$57.76M
32.47%
Sole
2.22M
Shared
0.00
None
0.00
Centessa Pharmaceuticals Inc
SOLEShares1.25M
TypeSH
Market value$16.47M
9.26%
Sole
1.25M
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares244.90K
TypeSH
Market value$13.07M
7.35%
Sole
244.90K
Shared
0.00
None
0.00
Alumis Inc
SOLEShares4.25M
TypeSH
Market value$12.74M
7.16%
Sole
4.25M
Shared
0.00
None
0.00
Rapt Therapeutics Inc
SOLEShares1.56M
TypeSH
Market value$12.50M
7.03%
Sole
1.56M
Shared
0.00
None
0.00
Bicara Therapeutics Inc
SOLEShares949.26K
TypeSH
Market value$8.82M
4.96%
Sole
949.26K
Shared
0.00
None
0.00
Edgewise Therapeutics Inc
SOLEShares585K
TypeSH
Market value$7.67M
4.31%
Sole
585K
Shared
0.00
None
0.00
Hinge Health Inc
SOLEShares135K
TypeSH
Market value$6.99M
3.93%
Sole
135K
Shared
0.00
None
0.00
Corvus Pharmaceuticals Inc
SOLEShares1.73M
TypeSH
Market value$6.92M
3.89%
Sole
1.73M
Shared
0.00
None
0.00
Kymera Therapeutics Inc
SOLEShares146.33K
TypeSH
Market value$6.39M
3.59%
Sole
146.33K
Shared
0.00
None
0.00
Verastem Inc
SOLEShares1.28M
TypeSH
Market value$5.30M
2.98%
Sole
1.28M
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares160K
TypeSH
Market value$5.01M
2.82%
Sole
160K
Shared
0.00
None
0.00
Cullinan Therapeutics Inc
SOLEShares594.02K
TypeSH
Market value$4.47M
2.51%
Sole
594.02K
Shared
0.00
None
0.00
Structure Therapeutics Inc
SOLEShares210K
TypeSH
Market value$4.36M
2.45%
Sole
210K
Shared
0.00
None
0.00
Allogene Therapeutics Inc
SOLEShares2.88M
TypeSH
Market value$3.25M
1.83%
Sole
2.88M
Shared
0.00
None
0.00
Ideaya Biosciences Inc
SOLEShares144.47K
TypeSH
Market value$3.04M
1.71%
Sole
144.47K
Shared
0.00
None
0.00
Avidity Biosciences Inc
SOLEShares40K
TypeSH
Market value$1.14M
0.64%
Sole
40K
Shared
0.00
None
0.00
Spyre Therapeutics Inc
SOLEShares70K
TypeSH
Market value$1.05M
0.59%
Sole
70K
Shared
0.00
None
0.00
Casi Pharmaceuticals Inc
SOLEShares787.12K
TypeSH
Market value$928.8K
0.52%
Sole
787.12K
Shared
0.00
None
0.00
Viridian Therapeutics, Inc
SOLEShares1.97K
TypeSH
Market value$27.6K
0.02%
Sole
1.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 2.22M | SH | $57.76M 32.47% | 2.22M | 0.00 | 0.00 |
Centessa Pharmaceuticals IncSOLE | SPONSORED ADS | 1.25M | SH | $16.47M 9.26% | 1.25M | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | COM | 244.90K | SH | $13.07M 7.35% | 244.90K | 0.00 | 0.00 |
Alumis IncSOLE | COM | 4.25M | SH | $12.74M 7.16% | 4.25M | 0.00 | 0.00 |
Rapt Therapeutics IncSOLE | COM | 1.56M | SH | $12.50M 7.03% | 1.56M | 0.00 | 0.00 |
Bicara Therapeutics IncSOLE | COM | 949.26K | SH | $8.82M 4.96% | 949.26K | 0.00 | 0.00 |
Edgewise Therapeutics IncSOLE | COM | 585K | SH | $7.67M 4.31% | 585K | 0.00 | 0.00 |
Hinge Health IncSOLE | CL A | 135K | SH | $6.99M 3.93% | 135K | 0.00 | 0.00 |
Corvus Pharmaceuticals IncSOLE | COM | 1.73M | SH | $6.92M 3.89% | 1.73M | 0.00 | 0.00 |
Kymera Therapeutics IncSOLE | COM | 146.33K | SH | $6.39M 3.59% | 146.33K | 0.00 | 0.00 |
Verastem IncSOLE | COM | 1.28M | SH | $5.30M 2.98% | 1.28M | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | COM | 160K | SH | $5.01M 2.82% | 160K | 0.00 | 0.00 |
Cullinan Therapeutics IncSOLE | COM | 594.02K | SH | $4.47M 2.51% | 594.02K | 0.00 | 0.00 |
Structure Therapeutics IncSOLE | SPONSORED ADS | 210K | SH | $4.36M 2.45% | 210K | 0.00 | 0.00 |
Allogene Therapeutics IncSOLE | COM | 2.88M | SH | $3.25M 1.83% | 2.88M | 0.00 | 0.00 |
Ideaya Biosciences IncSOLE | COM | 144.47K | SH | $3.04M 1.71% | 144.47K | 0.00 | 0.00 |
Avidity Biosciences IncSOLE | COM | 40K | SH | $1.14M 0.64% | 40K | 0.00 | 0.00 |
Spyre Therapeutics IncSOLE | COM | 70K | SH | $1.05M 0.59% | 70K | 0.00 | 0.00 |
Casi Pharmaceuticals IncSOLE | ORD SHS | 787.12K | SH | $928.8K 0.52% | 787.12K | 0.00 | 0.00 |
Viridian Therapeutics, IncSOLE | COM | 1.97K | SH | $27.6K 0.02% | 1.97K | 0.00 | 0.00 |